San Clemente-based ICU Medical Inc. is in talks about a possible sale to a Chicago-based private equity firm, according to a published report.
ICU makes needleless intravenous connectors and other medical devices.
Bloomberg reported that ICU was in exclusive talks to sell itself to GTCR LLC, a private equity firm. The firm has lined up as much as $750 million in financing for a potential deal, the report said.
ICU recently had a market value of nearly $1.1 billion. Its shares got a boost last month after Bloomberg reported that the device maker engaged JPMorgan Chase & Co. to look at a deal that could fetch up to $1 billion.
GTCR invests in various sectors, including healthcare.
ICU, GTCR and JPMorgan declined to comment to Bloomberg, the publication said.
―Vita Reed
